A Low Serum γ-Glutamyltransferase Level Predicts a Sustained Virological Response in Patients with Chronic Hepatitis C Genotype 1

참고문헌 (12)

1. Fatih Güzelbulut, "A Lower Serum Gamma-Glutamyltransferase Level Does Not Predict a Sustained Virological Response in Patients with Chronic Hepatitis C Genotype 1", Gut and Liver, 7(1), pp.74~81 (2013), 거트앤리버 발행위원회
2. Villela-Nogueira CA, "Gamma-glutamyl transferase (GGT) as an independent predictive factor of sustained virologic response in patients with hepatitis C treated with interferon-alpha and ribavirin", J Clin Gastroenterol, 39, pp.728~730 (2005)
3. Kau A, "Treatment predictors of a sustained virologic response in hepatitis B and C", J Hepatol, 49, pp.634~651 (2008)
4. Bergmann JF, "Gamma-glutamyltransferase and rapid virological response as predictors of successful treatment with experimental or standard peginterferon-alpha-2b in chronic hepatitis C non-responders", Liver Int, 27, pp.1217~1225 (2007)
5. Akuta N, "Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholesterol levels", J Hepatol, 46, pp.403~410 (2007)
6. Ishak K, "Histological grading and staging of chronic hepatitis", J Hepatol, 22, pp.696~699 (1995)
7. Dogan UB, "The comparison of the efficacy of pegylated interferon alpha-2a and alpha-2b in chronic hepatitis C patients with genotype 1", Eur J Gastroenterol Hepatol, 25, pp.1082~1085 (2013)
8. 장재영, "Chronic Hepatitis C", Gut and Liver, 5(2), pp.117~132 (2011), 거트앤리버 발행위원회
9. Ghany MG, "Seeff LB; American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update", Hepatology, 49, pp.1335~1374 (2009)
10. Poordad FF, "Review article: the role of rapid virological response in determining treatment duration for chronic hepatitis C", Aliment Pharmacol Ther, 31, pp.1251~1267 (2010)
11. McHutchison JG, "qPeginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection", N Engl J Med, 361, pp.580~593 (2009)
12. Dogan UB, "Sustained virological response based on the week 4 response in hepatitis C virus genotype 1 patients treated with peginterferons alpha-2a and alpha-2b, plus ribavirin", Eur J Gastroenterol Hepatol, 25, pp.1317~1320 (2013)